Changes in expression of the neuropeptide Y Y1 receptor gene in the medial amygdala of transgenic mice during pregnancy and after delivery

Journal of Neurochemistry

Volumn 82, Issue 5, 2002, Pages 1272-1281

  Oberto, Alessandra ^a   Serra, Mariangela ^b   Pisu, Maria Giuseppina ^b   Biggio, Giovanni ^b   Eva, Carola ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Amygdala; Neuroactive steroids; Pregnancy; Transgenic mice; Y1 receptor for neuropeptide Y

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; BETA GALACTOSIDE; FINASTERIDE; MESSENGER RNA; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE YY1 RECEPTOR; PROGESTERONE; STEROID 5ALPHA REDUCTASE INHIBITOR; TETRAHYDRODEOXYCORTICOSTERONE; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DELIVERY; ENZYME ACTIVITY; FEMALE; GABAERGIC SYSTEM; GENE EXPRESSION; HISTOCHEMISTRY; HORMONE DETERMINATION; IN SITU HYBRIDIZATION; MOUSE; NEUROCHEMISTRY; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RNA ANALYSIS; TRANSGENE; TRANSGENIC MOUSE;

AMYGDALA; ANIMALS; CEREBRAL CORTEX; DESOXYCORTICOSTERONE; ENZYME INHIBITORS; FEMALE; FINASTERIDE; GENE EXPRESSION REGULATION; GENES, REPORTER; IN SITU HYBRIDIZATION; MICE; MICE, TRANSGENIC; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY, ANIMAL; PREGNANOLONE; PROGESTERONE; RECEPTORS, NEUROPEPTIDE Y; RNA, MESSENGER; TRANSGENES;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0036724802     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01079.x     Document Type: Article

References (74)

1. The amigdala mediates the anxiolitic-like effect of neurosteroid allopregnanolone in rat
2. Neuropeptide Y in cortex and striatum. Ultrastructural distribution and coexistence with classical neurotransmitters and neuropeptides
3. Inhibition of rat α-reductases by finasteride: Evidence for isozyme differences in the mechanism of inhibition
4. Behavioral characterization of neuropeptide Y knockout mice
5. Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one
6. A-receptor plasticity during long-term exposure to and withdrawal from progesterone
7. A receptor
8. Anxiolytic activity of NPY receptor agonists in the conflict test
9. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze
10. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures
11. A receptors
12. 35S]-TBPS binding in the brain of rats exposed to isoniazid, pentylenetetrazol or stress
13. Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery
14. A receptor plasticity by progesterone metabolites
15. Neurotransmission in the rat amygdala related to fear and anxiety
16. A receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal
17. Neurosteroids and behavior
18. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
19. 1 receptor gene expression in the medial amygdaloid nucleus of transgenic mice
20. A receptor complex during pregnancy and after delivery in the rat brain
21. A receptor expression and function during progesterone treatment and withdrawal
22. A receptor plasticity during long-term exposure and withdrawal from progesterone
23. The neurosteroid 3α,5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy
24. Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat
25. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?
26. Current perspectives on the role of neurosteroids in PMS and depression
27. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats
28. Neuropeptide Y localization in the rat amygdaloid complex
29. 1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding
30. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models
31. 1 receptors in amygdala, and dissociation from food intake effects
32. Corticotropin-releasing factor and neuropeptide Y: Role in emotional integration
33. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y
34. Organization of NPY neurons in the mammalian central nervous system
35. Neuropeptide-containing neurons of the cerebral cortex are also GABAergic
36. Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations
37. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight
38. 1 receptor antagonist BIBP3226: Antagonism with diazepam
39. 1 receptor antagonist BIBP3226 in rats
40. 1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: Functional antagonism of corticotropin-releasing hormone-induced anxiety
41. Anticonvulsant activity of neurosteroids: Correlation with γ-aminobutyric acid-evoked chloride current potentiation
42. A receptor function
43. Emotion: Circuits in the brain
44. Protein measurement with the folin phenol reagent
45. A receptor. Mechanism of action and physiological significance
46. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
47. Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala
48. 2 receptors on neuropeptide Y-induced sensitization to sedation
49. 1-mediated mechanism
50. 1 receptor 5′ upstream sequence directs cell-specific and developmentally regulated LacZ expression in transgenic mice CNS
51. 1 receptor gene expression in the medial amygdala of transgenic mice
52. 1 network in the medial amygdala: A neuroanatomical basis for their functional interaction
53. GABAergic nature of hypothalamic leptin target neurones in the ventromedial arcuate nucleus
54. Neuroactive steroids
55. Interactions between neuropeptide Y and γ-aminobutyric acid in stimulation of feeding: A morphological and pharmacological analysis
56. A receptors
57. Synthesis, metabolism and pharmacological activity of 3α-hydroxy-steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes
58. Neuroactive steroids: Mechanisms of action and neuropsychopharmacological perspectives
59. Progesterone receptor-mediated neuroactive steroids
60. 1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test
61. A receptor function in rat brain
62. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
63. A receptor α4 subunit in association with increased anxiety
64. Neuropeptide Y - A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide
65. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression
66. Neuropeptide Y: Emerging evidence for a functional role in seizure modulation
67. 1 receptors by antisense oligodeoxynucleotides
68. Neuroactive steroids and central nervous system disorders
69. 1 receptor agonists
70. Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one
71. In situ hybridization with oligonucleotide probes
72. Neuropeptide Y reverses corticotropin-releasing hormone- and psychological stress-caused shortening of sodium pentobarbital-induced sleep in rats